Visamerin/Mulsevo

Sanofi Singles Out Top Pipeline Prospects, New Cost Cuts
Motley Fool
Tue, 09/6/11 - 12:17 pm
Sanofi
Genzyme
Kynamro
Visamerin/Mulsevo
Zaltrap
Lemtrada
Aubagio
Lyxumia